farmacéuticas

Corporate tax dodging is fuelling the inequality crisis, and it is poor women who pay the highest price. Join Oxfam to demand that drug companies pay their fair share of taxes, make their medicines affordable and stop undermining the fight against inequality and poverty.  

Oxfam has hailed the Indian Supreme Court’s ruling against a patent protection petition filed by multinational pharmaceutical company Novartis as a huge victory for public health.

 

 

Mohga Kamal-Yanni, Oxfam senior policy adviser, said: “Oxfam is delighted that GAVI has raised more than $4bn to vaccinate children against killer diseases.

New Oxfam report: The proliferation of substandard medicines in poor countries is being used by rich countries as an excuse to tighten intellectual property rules, boosting the profits of large pharmaceutical companies while making it harder for poor people to get access to the medicines they need.

Poor-quality, or “substandard”, medicines threaten patients and public health in developing countries.